These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16522988)

  • 1. Segmental vitiligo and hair curling after interferon alpha and ribavirin treatment for hepatitis C.
    Tinio P; Hadi S; Al-Ghaithi K; Al-Qari H; Rudikoff D
    Skinmed; 2006; 5(1):50-1. PubMed ID: 16522988
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report.
    Tomasiewicz K; Modrzewska R; Semczuk G
    Adv Ther; 2006; 23(1):139-42. PubMed ID: 16644614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitiligo and alopecia in patients with chronic hepatitis C treated with alpha interferon associated or not with ribavirin].
    Primo J; Merino C; Gómez Belda AB
    Gastroenterol Hepatol; 2000; 23(7):362-3. PubMed ID: 11002542
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.
    Oiso N; Sato M; Kawada A
    J Dermatol; 2013 Sep; 40(9):772-3. PubMed ID: 23855823
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.
    Nouri K; Busso M; Machler BC
    Cutis; 1997 Dec; 60(6):289-90. PubMed ID: 9426968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
    Callens S; Bottieau E; Michielsen P; Colebunders R
    AIDS; 2004 Jan; 18(1):131. PubMed ID: 15090841
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon-induced vitiligo in hepatitis C patients: a case series.
    Hamadah I; Binamer Y; Sanai FM; Abdo AA; Alajlan A
    Int J Dermatol; 2010 Jul; 49(7):829-33. PubMed ID: 20618507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid nephrolithiasis associated with interferon and ribavirin treatment of hepatitis C.
    Fontana RJ
    Dig Dis Sci; 2001 Apr; 46(4):920-4. PubMed ID: 11330434
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anterior uveitis in a patient treated with pegylated interferon and ribavirin].
    Carneros Martín JA; Fuentes Coronel A; Alvarez Delgado A; González San Martín F
    Med Clin (Barc); 2003 Mar; 120(9):359. PubMed ID: 12646118
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
    Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
    Sprenger R; Sagmeister M; Offner F
    Gut; 2005 Mar; 54(3):438-9; author reply 439. PubMed ID: 15710996
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitiligo occurring at site of interferon-alpha 2b injection in a patient with chronic viral hepatitis C: a case report.
    Anbar TS; Abdel-Rahman AT; Ahmad HM
    Clin Exp Dermatol; 2008 Jul; 33(4):503. PubMed ID: 18498412
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection. A rare complication.
    Ortega-Ibarra FS; Remes-Troche JM
    Rev Esp Enferm Dig; 2013; 105(5):291-2. PubMed ID: 23971660
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thyroid alterations following treatment with pegylated interferon and ribavirin: differences between HIV-coinfected and non-coinfected patients].
    Montes-Ramírez ML; Rodríguez-Zapata M
    Enferm Infecc Microbiol Clin; 2006 Mar; 24(3):213-4. PubMed ID: 16606567
    [No Abstract]   [Full Text] [Related]  

  • 15. Onset of dermatitis herpetiformis after treatment by interferon and ribavirin for chronic hepatitis C.
    Borghi-Scoazec G; Merle P; Scoazec JY; Claudy A; Trepo C
    J Hepatol; 2004 May; 40(5):871-2. PubMed ID: 15094241
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 17. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
    Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
    Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
    [No Abstract]   [Full Text] [Related]  

  • 18. Peginterferon and ribavirin for hepatitis C.
    Ben Salem C; Hmouda H; Bouraoui K
    N Engl J Med; 2007 Mar; 356(12):1270; author reply 1271. PubMed ID: 17380578
    [No Abstract]   [Full Text] [Related]  

  • 19. Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature.
    Tahan V; Ozseker F; Guneylioglu D; Baran A; Ozaras R; Mert A; Ucisik AC; Cagatay T; Yilmazbayhan D; Senturk H
    Dig Dis Sci; 2003 Jan; 48(1):169-73. PubMed ID: 12645805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of therapy for chronic hepatitis C.
    Russo MW; Fried MW
    Gastroenterology; 2003 May; 124(6):1711-9. PubMed ID: 12761728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.